These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16084311)

  • 1. Saccharomyces boulardii: basic science and clinical applications in gastroenterology.
    Buts JP; Bernasconi P
    Gastroenterol Clin North Am; 2005 Sep; 34(3):515-32, x. PubMed ID: 16084311
    [No Abstract]   [Full Text] [Related]  

  • 2. Saccharomyces boulardii: a summary of the evidence for gastroenterology clinical practice in adults and children.
    Berni Canani R; Cucchiara S; Cuomo R; Pace F; Papale F
    Eur Rev Med Pharmacol Sci; 2011 Jul; 15(7):809-22. PubMed ID: 21780551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of the digestive microbiota in a gnotobiotic mouse model during antibiotic treatment: Influence of Saccharomyces boulardii.
    Barc MC; Charrin-Sarnel C; Rochet V; Bourlioux F; Sandré C; Boureau H; Doré J; Collignon A
    Anaerobe; 2008 Oct; 14(4):229-33. PubMed ID: 18511310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of probiotics in humans: an analysis of the literature.
    Floch MH; Montrose DC
    Gastroenterol Clin North Am; 2005 Sep; 34(3):547-70, x. PubMed ID: 16084313
    [No Abstract]   [Full Text] [Related]  

  • 5. Probiotics, prebiotics, and synbiotics.
    de Vrese M; Schrezenmeir J
    Adv Biochem Eng Biotechnol; 2008; 111():1-66. PubMed ID: 18461293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes.
    Dalmasso G; Cottrez F; Imbert V; Lagadec P; Peyron JF; Rampal P; Czerucka D; Groux H; Foussat A; Brun V
    Gastroenterology; 2006 Dec; 131(6):1812-25. PubMed ID: 17087945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children.
    Szajewska H; Skórka A; Dylag M
    Aliment Pharmacol Ther; 2007 Feb; 25(3):257-64. PubMed ID: 17269987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is dietary fiber useful in intestinal functional diseases?].
    Frexinos J
    Gastroenterol Clin Biol; 1999 Jun; 23(5 Pt 2):B130-4. PubMed ID: 10897784
    [No Abstract]   [Full Text] [Related]  

  • 9. Review article: yeast as probiotics -- Saccharomyces boulardii.
    Czerucka D; Piche T; Rampal P
    Aliment Pharmacol Ther; 2007 Sep; 26(6):767-78. PubMed ID: 17767461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Saccharomyces boulardii on cytokine secretion from intraepithelial lymphocytes infected by Escherichia coli and Candida albicans.
    Fidan I; Kalkanci A; Yesilyurt E; Yalcin B; Erdal B; Kustimur S; Imir T
    Mycoses; 2009 Jan; 52(1):29-34. PubMed ID: 18627477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors.
    Wu X; Vallance BA; Boyer L; Bergstrom KS; Walker J; Madsen K; O'Kusky JR; Buchan AM; Jacobson K
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G295-306. PubMed ID: 18032474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive infections due to Saccharomyces boulardii (Ultra-levure).
    Prescrire Int; 2007 Jun; 16(89):110. PubMed ID: 17582930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotics as functional food in the treatment of diarrhea.
    Yan F; Polk DB
    Curr Opin Clin Nutr Metab Care; 2006 Nov; 9(6):717-21. PubMed ID: 17053425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida albicans Berthout, 1923: hydrolases activity and own method of digestive tract strains biotyping.
    Kurnatowski M; Wasowska-Królikowska K; Kurnatowska A
    Wiad Parazytol; 2002; 48(4):441-5. PubMed ID: 16894729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highlighting immunity in the digestive tract: basic science and translational opportunities.
    Rossi M; Bot A
    Int Rev Immunol; 2009; 28(6):395-6. PubMed ID: 19954355
    [No Abstract]   [Full Text] [Related]  

  • 16. Technology insight: metabonomics in gastroenterology-basic principles and potential clinical applications.
    Bjerrum JT; Nielsen OH; Wang YL; Olsen J
    Nat Clin Pract Gastroenterol Hepatol; 2008 Jun; 5(6):332-43. PubMed ID: 18431374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tools for stools: the challenge of assessing human intestinal microbiota using molecular diagnostics.
    Brugère JF; Mihajlovski A; Missaoui M; Peyret P
    Expert Rev Mol Diagn; 2009 May; 9(4):353-65. PubMed ID: 19435456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of Saccharomyces cerevisiae strains from different food matrices and their preliminary selection for a potential use as probiotics.
    Pennacchia C; Blaiotta G; Pepe O; Villani F
    J Appl Microbiol; 2008 Dec; 105(6):1919-28. PubMed ID: 19120638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ecology and pathogenicity of gastrointestinal Streptococcus bovis.
    Herrera P; Kwon YM; Ricke SC
    Anaerobe; 2009; 15(1-2):44-54. PubMed ID: 19100852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of alpha,alpha-trehalase released in the intestinal lumen by the probiotic Saccharomyces boulardii.
    Buts JP; Stilmant C; Bernasconi P; Neirinck C; De Keyser N
    Scand J Gastroenterol; 2008; 43(12):1489-96. PubMed ID: 18777247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.